Swiss Recommendations for Cutaneous Basal Cell Carcinoma. release_3zhprf6xdjed7o3bq4kvkb5h6y

by Egle Ramelyte, Mirjam C Nägeli, Robert Hunger, Rastine Merat, Olivier Gaide, Alexander A Navarini, Antonio Cozzio, Nikolaus B Wagner, Lara Valeska Maul, Reinhard Dummer

Published by Karger.

2022  

Abstract

Basal cell carcinoma (BCC) is the most common nonmelanoma skin cancer in Switzerland and worldwide. Most BCCs can be treated in a curative setting. However, patients can develop locally destructive and, rarely, metastatic tumors that require a different treatment approach. The clinical subtype of individual lesions provides prognostic information and influences management decisions. Surgical excision, topical therapies, and radiotherapy are highly effective in the majority of subtypes as well as in low- and high-risk diseases. For patients with low-risk diseases and superficial tumors not amenable to surgery, several nonsurgical alternatives are available. Systemic therapy is indicated for high-risk BCCs, which are not amenable to either surgery or radiotherapy. Hedgehog pathway inhibitors (HHI) are currently approved. Other therapeutic options such as immune checkpoint inhibitors show promising results in clinical trials. This first version of Swiss recommendations for diagnosis and management of BCC was prepared through extensive literature review and an advisory board consensus of expert dermatologists and oncologists in Switzerland. The present guidelines recommend therapies based on a multidisciplinary team approach and rate of recurrence for individual lesions. Based on the risk of recurrence, two distinct groups have been identified: low-risk (easy-to-treat) and high-risk (difficult-to-treat) tumors. Based on these classifications, evidence-based recommendations of available therapies are presented herein.
In text/plain format

Archived Files and Locations

application/pdf  403.5 kB
file_6h7ubs6osrae3czplsaewxgbfa
boris.unibe.ch (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2022-09-22
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: afd6d2b8-6c0a-49c0-8d55-270ecbb9138a
API URL: JSON